RS54269B1 - Derivati pirazola korisni kao inhibitori aldosteron sintaze - Google Patents
Derivati pirazola korisni kao inhibitori aldosteron sintazeInfo
- Publication number
- RS54269B1 RS54269B1 RS20150619A RSP20150619A RS54269B1 RS 54269 B1 RS54269 B1 RS 54269B1 RS 20150619 A RS20150619 A RS 20150619A RS P20150619 A RSP20150619 A RS P20150619A RS 54269 B1 RS54269 B1 RS 54269B1
- Authority
- RS
- Serbia
- Prior art keywords
- mmol
- benzonitrile
- compound
- pharmaceutically acceptable
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161496657P | 2011-06-14 | 2011-06-14 | |
| US201161506349P | 2011-07-11 | 2011-07-11 | |
| PCT/US2012/041212 WO2012173849A1 (en) | 2011-06-14 | 2012-06-07 | Pyrazole derivatives useful as aldosterone synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS54269B1 true RS54269B1 (sr) | 2016-02-29 |
Family
ID=46317515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20150619A RS54269B1 (sr) | 2011-06-14 | 2012-06-07 | Derivati pirazola korisni kao inhibitori aldosteron sintaze |
Country Status (33)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016002918A1 (ja) * | 2014-07-04 | 2016-01-07 | 日本たばこ産業株式会社 | インドール化合物の製造方法 |
| CN108586221B (zh) * | 2018-06-26 | 2021-03-02 | 常州制药厂有限公司 | 用于制备替卡格雷的中间体及其制备方法 |
| CN112409432B (zh) * | 2020-11-16 | 2023-07-07 | 陕西理工大学 | 一种依西美坦的合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57165369A (en) * | 1981-04-06 | 1982-10-12 | Teijin Ltd | Pyrazole derivative and its preparation |
| US4617307A (en) | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
| US5057521A (en) * | 1988-10-26 | 1991-10-15 | Ciba-Geigy Corporation | Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism |
| GT200600381A (es) * | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| JPWO2007111175A1 (ja) | 2006-03-17 | 2009-08-13 | 日本碍子株式会社 | 目封止ハニカム構造体の製造方法 |
| ES2472446T3 (es) | 2009-11-30 | 2014-07-01 | Novartis Ag | Derivados de imidazol como inhibidores de aldosterona sintasa |
| PL2523731T3 (pl) | 2010-01-14 | 2019-04-30 | Novartis Ag | Zastosowanie środka modyfikującego hormon nadnerczy |
-
2012
- 2012-06-04 AR ARP120101967A patent/AR086665A1/es unknown
- 2012-06-04 TW TW101120004A patent/TWI518073B/zh not_active IP Right Cessation
- 2012-06-07 SI SI201230283T patent/SI2721009T1/sl unknown
- 2012-06-07 DK DK12727984.2T patent/DK2721009T3/en active
- 2012-06-07 AU AU2012271023A patent/AU2012271023A1/en not_active Abandoned
- 2012-06-07 PH PH1/2013/502597A patent/PH12013502597A1/en unknown
- 2012-06-07 EP EP12727984.2A patent/EP2721009B1/en active Active
- 2012-06-07 PE PE2013002810A patent/PE20140606A1/es not_active Application Discontinuation
- 2012-06-07 SG SG2013082367A patent/SG194822A1/en unknown
- 2012-06-07 RS RS20150619A patent/RS54269B1/sr unknown
- 2012-06-07 MX MX2013014790A patent/MX336042B/es unknown
- 2012-06-07 ES ES12727984.2T patent/ES2548210T3/es active Active
- 2012-06-07 US US13/490,530 patent/US8778984B2/en not_active Expired - Fee Related
- 2012-06-07 WO PCT/US2012/041212 patent/WO2012173849A1/en not_active Ceased
- 2012-06-07 PT PT127279842T patent/PT2721009E/pt unknown
- 2012-06-07 HU HUE12727984A patent/HUE026461T2/en unknown
- 2012-06-07 ME MEP-2015-131A patent/ME02223B/me unknown
- 2012-06-07 HR HRP20150939TT patent/HRP20150939T1/hr unknown
- 2012-06-07 KR KR1020137032885A patent/KR101555119B1/ko not_active Expired - Fee Related
- 2012-06-07 CA CA2836804A patent/CA2836804C/en not_active Expired - Fee Related
- 2012-06-07 EA EA201391655A patent/EA201391655A1/ru unknown
- 2012-06-07 JP JP2014515877A patent/JP5890012B2/ja not_active Expired - Fee Related
- 2012-06-07 CN CN201280028717.6A patent/CN103596930B/zh not_active Expired - Fee Related
- 2012-06-07 PL PL12727984T patent/PL2721009T3/pl unknown
- 2012-06-07 BR BR112013031873A patent/BR112013031873A2/pt not_active IP Right Cessation
-
2013
- 2013-11-18 CR CR20130601A patent/CR20130601A/es unknown
- 2013-11-18 IL IL229485A patent/IL229485A0/en unknown
- 2013-12-02 DO DO2013000284A patent/DOP2013000284A/es unknown
- 2013-12-10 CL CL2013003536A patent/CL2013003536A1/es unknown
- 2013-12-11 GT GT201300307A patent/GT201300307A/es unknown
- 2013-12-11 CO CO13290174A patent/CO6821955A2/es active IP Right Grant
- 2013-12-13 EC ECSP13013080 patent/ECSP13013080A/es unknown
-
2015
- 2015-09-11 CY CY20151100789T patent/CY1116687T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2903394C (en) | Arginine methyltransferase inhibitors and uses thereof | |
| JP7337951B2 (ja) | 癌を治療するための窒素含有芳香族ヘテロ環アミド誘導体 | |
| JP5433418B2 (ja) | 多環式化合物 | |
| JP6854496B2 (ja) | 三環式ヘテロアリール基含有化合物 | |
| EP3870586B1 (en) | Fused pentacyclic imidazole derivatives as modulators of tnf activity | |
| EP1999111B1 (en) | Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists | |
| CN110041333B (zh) | 溴结构域抑制剂化合物及其用途 | |
| UA71610C2 (uk) | Біциклічні гетероцикли та фармацевтична композиція на їх основі | |
| CN110891950B (zh) | 一种三嗪化合物及其药学上可接受的盐 | |
| CA2707722A1 (en) | Gamma secretase modulators | |
| WO2019228443A1 (en) | Selective estrogen receptor downregulators and uses thereof | |
| RS54269B1 (sr) | Derivati pirazola korisni kao inhibitori aldosteron sintaze | |
| CA3208671C (en) | Selective estrogen receptor degraders | |
| EP1966203B1 (en) | Oxazoloisoquinoline derivatives as thrombin receptor antagonists | |
| JP6884973B2 (ja) | 疼痛に対して活性を有するオキサジアザスピロ化合物 | |
| JP2018531263A6 (ja) | 疼痛に対して活性を有するオキサジアザスピロ化合物 | |
| KR20240021758A (ko) | 시그마 리간드로서 신규 피라졸로[1,5-a]피리미딘 유도체 | |
| NZ617642B2 (en) | Pyrazole derivatives useful as aldosterone synthase inhibitors | |
| WO2025237765A1 (en) | Benzimidazole derivatives and pharmaceutical compositions thereof for the treatment of cancer | |
| CN112851741A (zh) | 一种取代的甾体类化合物及其应用 | |
| WO2006104008A1 (ja) | ウレア誘導体、それを含有する医薬組成物およびそれらの医薬用途 | |
| CN115611910A (zh) | 氨基喹唑啉类化合物的制备方法 |